Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Nektar Therapeutics synthesizes promising thymidylate synthase inhibitor

Nov. 9, 2012

Sloan-Kettering Institute for Cancer Research patents new HSP 90 inhibitors

Nov. 9, 2012

IMA-901 receives FDA orphan designation, phase III study completes enrollment

Nov. 9, 2012

T-3256336 proven to be a highly effective inhibitor of tumor growth in vivo

Nov. 9, 2012

FDA grants fast track status for etirinotecan pegol in metastatic breast cancer

Nov. 9, 2012

Senesco Technologies expands study of SNS01-T

Nov. 9, 2012

Kancera reports preclinical data for pancreatic cancer compounds

Nov. 9, 2012

Aileron Therapeutics develops new oncology drug candidate

Nov. 8, 2012

Bristol-Myers Squibb patents new lysophospholipid receptor antagonists

Nov. 8, 2012

Bayer presents new protein kinase Akt inhibitors for cancer

Nov. 8, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...